Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections
- PMID: 21099222
- DOI: 10.1159/000321018
Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections
Abstract
The increasing emergence of serious multidrug-resistant (MDR) Gram-negative infections has led to a new health-care crisis. These infections predominately include MDR Pseudomonas aeruginosa, extended-spectrum beta-lactamase-producing Enterobacteriaceae and MDR Acinetobacter baumannii. These organisms are present in a variety of clinical settings, but there is a distinct paucity of antibiotics to effectively treat these infections. The increasing use of broad-spectrum antibiotics and lack of good stewardship have contributed to the increase in these MDR organisms. This review focuses on the main MDR Gram-negative infections contributing to the current crisis in health care, their mechanisms of resistance and various treatment options for empiric therapy.
Copyright © 2010 S. Karger AG, Basel.
Similar articles
-
New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli.Semin Respir Crit Care Med. 2011 Apr;32(2):151-8. doi: 10.1055/s-0031-1275527. Epub 2011 Apr 19. Semin Respir Crit Care Med. 2011. PMID: 21506051 Review.
-
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.Expert Rev Anti Infect Ther. 2010 Jan;8(1):71-93. doi: 10.1586/eri.09.108. Expert Rev Anti Infect Ther. 2010. PMID: 20014903 Review.
-
Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.J Assoc Physicians India. 2009 Sep;57:636, 638-40, 645. J Assoc Physicians India. 2009. PMID: 20214000
-
Microbiology and drug resistance mechanisms of fully resistant pathogens.Curr Opin Microbiol. 2004 Oct;7(5):439-44. doi: 10.1016/j.mib.2004.08.007. Curr Opin Microbiol. 2004. PMID: 15451497 Review.
-
[Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].Mikrobiyol Bul. 2008 Oct;42(4):537-44. Mikrobiyol Bul. 2008. PMID: 19149074 Turkish.
Cited by
-
Highly selective end-tagged antimicrobial peptides derived from PRELP.PLoS One. 2011 Jan 27;6(1):e16400. doi: 10.1371/journal.pone.0016400. PLoS One. 2011. PMID: 21298015 Free PMC article.
-
Multi-drug resistant gram negative infections and use of intravenous polymyxin B in critically ill children of developing country: retrospective cohort study.BMC Infect Dis. 2014 Nov 28;14:626. doi: 10.1186/s12879-014-0626-9. BMC Infect Dis. 2014. PMID: 25430979 Free PMC article.
-
Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.J Antibiot (Tokyo). 2016 Jun;69(6):415-21. doi: 10.1038/ja.2015.127. Epub 2015 Dec 16. J Antibiot (Tokyo). 2016. PMID: 26669752 Free PMC article.
-
The opportunistic pathogen Pseudomonas aeruginosa activates the DNA double-strand break signaling and repair pathway in infected cells.Cell Mol Life Sci. 2013 Nov;70(22):4385-97. doi: 10.1007/s00018-013-1392-3. Epub 2013 Jun 13. Cell Mol Life Sci. 2013. PMID: 23760206 Free PMC article.
-
Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor.Antimicrob Agents Chemother. 2015 Jan;59(1):331-7. doi: 10.1128/AAC.04077-14. Epub 2014 Oct 27. Antimicrob Agents Chemother. 2015. PMID: 25348539 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical